Erdmann Stephan M, Abuzahra Faris, Merk Hans F, Schroeder Anja, Baron Jens M
Department of Dermatology and Allergology, University Hospital of RWTH Aachen, Aachen, Germany.
J Am Board Fam Pract. 2005 Mar-Apr;18(2):143-6. doi: 10.3122/jabfm.18.2.143.
Glucocorticoids are frequently used to treat allergic reactions. Therefore, allergic reactions to systemic glucocorticoids in particular are considered most unlikely and are not well known. We report on a 23-year-old woman with atopic dermatitis who had an anaphylactic reaction after oral administration of prednisolone. On treatment with epinephrine, antihistamines and volume symptoms resolved. Skin testing with a panel of glucocorticoids showed immediate type reactions to prednisolone, prednisolone hydrogen succinate, prednisone, and betamethasone dihydrogen phosphate. In challenge testing the patient tolerated methyl prednisolone and dexamethasone. There is increasing evidence that true allergic immediate type reactions to glucocorticoids exist. The severity of the reaction can vary from a rash to anaphylaxis. However, a patient sensitized to one or a group of glucocorticoids does not have to refrain from all types of glucocorticoids. Careful challenge testing is by far the best way to select glucocorticoids that are safe for future treatment. Clinicians should be aware that allergic reactions to glucocorticoids can occur and that worsening of symptoms does not always mean treatment failure.
糖皮质激素常用于治疗过敏反应。因此,对全身性糖皮质激素的过敏反应尤其被认为极不可能发生且鲜为人知。我们报告了一名23岁的特应性皮炎女性患者,她在口服泼尼松龙后发生了过敏反应。经肾上腺素、抗组胺药治疗后,症状缓解。一组糖皮质激素皮肤试验显示对泼尼松龙、琥珀酸氢化泼尼松、泼尼松和磷酸二氢倍他米松有速发型反应。在激发试验中,患者耐受甲泼尼龙和地塞米松。越来越多的证据表明,确实存在对糖皮质激素的真正速发型过敏反应。反应的严重程度可从皮疹到过敏反应不等。然而,对一种或一组糖皮质激素致敏的患者不必避免使用所有类型的糖皮质激素。目前,仔细的激发试验是选择未来治疗安全的糖皮质激素的最佳方法。临床医生应意识到,糖皮质激素过敏反应可能发生,症状恶化并不总是意味着治疗失败。